Abstract |
Type III hyperlipoproteinemia ( dysbetalipoproteinemia) is characterized by elevated concentrations of plasma cholesterol and triglycerides due to an increase in very low density lipoprotein (VLDL) remnant lipoproteins. In a retrospective analysis we observed that in 12 patients with this disorder, gemfibrozil reduced concentrations of total cholesterol, VLDL cholesterol and triglycerides by 48%, 72% and 68%, respectively. These changes were greater than those reported in a similar number of patients treated with clofibrate. Comparative data on the efficacy of different fibrates in this disorder are very limited; to assess this further we have compared the hypolipidemic effects of gemfibrozil (600 mg twice daily) and clofibrate (1 g twice daily) in six patients with well-characterized type III hyperlipoproteinemia. Baseline values were obtained after at least 8 weeks on diet and treatment values were obtained after 6 and 8 weeks of treatment with each drug. Treatment with clofibrate and gemfibrozil both resulted in significant reductions in the plasma concentrations of total cholesterol (40% and 54%), VLDL cholesterol (59% and 79%) and total triglycerides (48% and 70%), as well as a significant increase in HDL cholesterol (9% and 7%). Gemfibrozil was, however, significantly (P < 0.05) more effective in reducing plasma concentrations of total cholesterol, VLDL cholesterol and triglycerides than was clofibrate, in the same patients.
|
Authors | M L Larsen, D R Illingworth, J P O'Malley |
Journal | Atherosclerosis
(Atherosclerosis)
Vol. 106
Issue 2
Pg. 235-40
(Apr 1994)
ISSN: 0021-9150 [Print] Ireland |
PMID | 8060383
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Lipoproteins, VLDL
- Triglycerides
- Cholesterol
- Clofibrate
- Gemfibrozil
|
Topics |
- Adult
- Aged
- Cholesterol
(blood)
- Clofibrate
(therapeutic use)
- Female
- Gemfibrozil
(therapeutic use)
- Humans
- Hyperlipoproteinemia Type III
(blood, drug therapy)
- Lipoproteins, VLDL
(blood)
- Male
- Middle Aged
- Retrospective Studies
- Triglycerides
(blood)
|